Back
Xtacy Therapeutics 10K Form
Sell
32
XTCY.CX
Xtacy Therapeutics
Last Price:
0.03
Seasonality Move:
-22.76%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive XTCY.CX News And Ratings
See the #1 stock for the next 7 days that we like better than XTCY.CX
XTCY.CX Financial Statistics
Sales & Book Value
Annual Sales: | $21.83K |
---|---|
Cash Flow: | $0 |
Price / Cash Flow: | 0 |
Annual Sales: | $-0.01 |
Price / Book: | 0 |
Profitability
EPS (TTM): | -0.00340 |
---|---|
Net Income (TTM): | $-195.7K |
Gross Margin: | $19.54K |
Return on Equity: | 0% |
Return on Assets: | -62.02% |
Xtacy Therapeutics Earnings Forecast
Key Xtacy Therapeutics Financial Ratios
- The Gross Profit Margin over the past 16 years for XTCY.CX is 89.51%.
- The Selling, General & Administrative Expenses for XTCY.CX have been equal to 3,924.46% of Gross Profit Margin.
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 16 years have been positive in 9 years.
Xtacy Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | CNSX |
---|---|
Current Symbol: | XTCY.CX |
Website: | globalwellnessstrategies.com |
Debt
Debt-to-Equity Ratio: | -0.05 |
---|---|
Current Ratio: | 0.14 |
Quick Ratio: | 0.08 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
XTCY.CX Technical Analysis vs Fundamental Analysis
Sell
32
Xtacy Therapeutics (XTCY.CX)
is a Sell
Is Xtacy Therapeutics a Buy or a Sell?
-
Xtacy Therapeutics stock is rated a Sell
The current Xtacy Therapeutics [XTCY.CX] share price is $0.03. The Score for XTCY.CX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.